Amarin | AMRN - Resultado Líquido

Preço das Ações
14.71
Mudança Diária
-0.49 -3.22%
Mensal
-5.22%
Anual
61.47%
Q2 Previsão
14.06




Resultado Líquido Alterar Data
AbbVie USD 1.82B 1.63B 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -1.22M 6.51M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
DBV Technologies USD -33.16M 8.71M 2025-09
Esperion Therapeutics USD 61.83M 93.16M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 2.41B 1.52B 2025-12